-
Sisomicin, Netilmicin and Dibekacin: 1984 Review
2026-09-25
This 1984 review compares sisomicin, netilmicin and dibekacin by connecting their structural features and resistance-enzyme profiles with antibacterial activity, pharmacokinetics and clinical use. Its practical message is that isolate-level susceptibility and renal-function monitoring are essential: activity in vitro does not by itself predict treatment success or toxicity.
-
PDHA1 Succinylation Links α-KGA to Immune Escape
2026-09-25
A 2025 Nature Communications study connects PDHA1 lysine 83 succinylation with alpha-ketoglutarate accumulation and impaired macrophage antigen presentation in cholangiocarcinoma. Its proposed PDHA1–α-KG–OXGR1–MAPK pathway links tumor metabolic reprogramming to immune escape and offers a preclinical rationale for testing succinylation-directed intervention alongside chemotherapy.
-
KRAS Phase Separation in Colon Cancer
2026-09-24
Wang et al. report that farnesylation at KRAS C185 promotes cytoplasmic condensate formation, linking KRAS processing at the endoplasmic reticulum to stronger signaling and colon tumor growth. The study also finds that pitavastatin can disrupt this process and improve the response to a KRAS G12C inhibitor, while leaving important questions about clinical translation and treatment scope.
-
Sulfisomidine Workflows for Enzyme and Degradation Studies
2026-09-24
Sulfisomidine (sulfamethin) supports distinct bench workflows—from bacterial folate-pathway experiments and hPON1 enzyme kinetics to studies of sulfonamide transformation. A practical guide to preparing fresh solutions, selecting controls, interpreting matrix effects, and avoiding common assay pitfalls.
-
Biotin-HPDP for Cysteine-Linked Protein Assays
2026-09-23
Biotin-HPDP adds a cleavable biotin tag to accessible thiols, supporting enrichment and detection without permanently modifying the target. Applied to gasdermin D research, it can help test cysteine-centered hypotheses—but careful blocking, negative controls, and orthogonal functional assays are essential.
-
From OCRL Rescue to Translational Read-Through Strategy
2026-09-23
Patient-derived trabecular meshwork models are changing how Lowe syndrome therapies can be evaluated. This article connects the CRISPR and gene augmentation findings reported in Advanced Science with a practical, mutation-aware framework for investigating PTC124 (Ataluren) as an exploratory small-molecule comparator—not as a clinically validated treatment for Lowe syndrome.
-
PTC124 (Ataluren): OCRL Model Context
2026-09-22
PTC124 (Ataluren) is a small molecule designed to promote translational readthrough at selected premature termination codons. The 2026 Lowe syndrome study supports OCRL gene augmentation and CRISPR correction in patient-derived trabecular meshwork models, but it does not test ataluren directly: https://doi.org/10.1002/advs.77704.
-
Medroxyprogesterone Acetate in Decidualization Assays
2026-09-22
Medroxyprogesterone acetate is a useful experimental lens for connecting progestin signaling with endometrial metabolism. This article translates ACSL4-dependent fatty acid β-oxidation findings into practical assay design, controls, and interpretation strategies.
-
Medroxyprogesterone Acetate: Research Workflows
2026-09-21
Medroxyprogesterone acetate enables controlled steroid-hormone perturbation across endometrial, renal, and neurobiological models. This guide translates MPA solubility data and dose ranges into reproducible workflows, assay controls, and troubleshooting strategies.
-
Gamithromycin: Translational PK/PD for Respiratory Research
2026-09-21
Gamithromycin, also known as ML-1709460, offers a practical model for connecting 50S ribosomal inhibition with matrix-aware susceptibility testing, lung-focused exposure analysis, and AUC24h/MIC-driven translational decisions in bovine and swine respiratory research.
-
Dicloxacillin Activity Against Intracellular S. aureus
2026-09-20
The reference study established a combined cellular and murine framework for comparing dicloxacillin activity against intracellular and extracellular Staphylococcus aureus. Its central finding was that free-drug time above the MIC, rather than peak concentration or total exposure alone, best predicted efficacy in both bacterial compartments.
-
Geneticin, G-418 Sulfate: Selection Guide
2026-09-19
Geneticin, G-418 Sulfate is an aminoglycoside selection antibiotic for maintaining and isolating cells that express a neomycin resistance gene. This guide covers aqueous stock preparation, selection setup, quality control, and assay limitations; antiviral findings should remain restricted to the documented DENV-2/BHK context rather than generalized to other viruses or cell types.
-
Thymosin-β4, Notch/NF-κB, and Limb Ischemia
2026-09-18
The reference study shows that thymosin-β4 promotes endothelial angiogenic behavior and vascular marker expression in critical limb ischemia models through coordinated Notch and NF-κB pathway activity. Its combination of gain-of-function experiments with DAPT and BMS pathway inhibition provides a useful mechanistic framework for studying ischemic neovascularization, while remaining limited by preclinical models and pharmacological specificity.
-
Isorhamnetin in Oocyte Maturation Research
2026-09-18
Isorhamnetin is a flavonoid compound that promoted porcine oocyte maturation at 10 μM for 44 hours in a peer-reviewed study. The reported mechanism involved PI3K/Akt activation, reduced oxidative and endoplasmic-reticulum stress, and lower apoptosis-associated signaling.
-
Sulfo-Cy3 Azide for Translational Neurogenetics
2026-09-17
A mechanistic and strategic guide to using Sulfo-Cy3 azide as a water-compatible bioconjugation reagent for mapping developmental neurogenetic signals, including Nurr1-positive neuronal populations, with stronger control over labeling fidelity and imaging performance.